 |
 |
|
|
|
| Imatinib mesylate |
 |
| Imatinib mesylate |
 |
| 220127-57-1 |
 |
Imatinib mesylate
CAS: 220127-57-1
MF: C30H35N7O4S
MW: 589.71
Description: White crystalline powder.
Usage: A tyrosine kinase inhibitor, Highly specific for BCR-ABL, the enzyme associated with chronic myelogenous leukemia (CML) and certain forms of acute lymphoblastic leukemia (ALL).
Standard: Enterprise standard
|
 |
| antineoplastics |
|
|
|
|
|
